|
Loading...
| ||||||||||||||
Recent Publications by Lonza Biologics: |  | |
| Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: Improving the efficiency of cell line generation.
Transfectants with a wide range of cellular phenotypes are obtained during... | Lonza Biologics plc, 228 Bath Road, Slough, Berkshire, SL1 4DX, U.K. | Biotechnol Prog. 2010 Apr 22.
DOI Direct Link |
| Strategies for selecting Recombinant CHO cell lines for cGMP manufacturing: Realizing the potential in bioreactors.
Manufacture of recombinant proteins from mammalian cell lines requires the... | Lonza Biologics plc, 228 Bath Road, Slough, Berkshire, U.K. | Biotechnol Prog. 2010 Apr 22.
DOI Direct Link |
| Scale-up of monoclonal antibody purification processes.
Mammalian cell culture technology has improved so rapidly over the last... | Lonza Biologics, Purification Development, 228 Bath Road, Slough, | J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):64-78.
DOI Direct Link |
| Process analytics for purification of monoclonal antibodies.
The application of appropriate analytical methods is an essential... | Lonza Biologics Plc, 228 Bath Road, Slough, Berkshire SL1 4DX, UK. | J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):79-87.
DOI Direct Link |
| Toward more efficient protein expression: keep the message simple.
Optimization of gene coding-sequence, including preferred codon usage and... | Lonza Biologics, plc., 224 Bath Road, Slough, SL1 4DX, UK. | Mol Biotechnol. 2006 Oct;34(2):151-6.
DOI Direct Link |
Lonza Biologics Patents: |  |
| US Patent No. | Title |
| 7439037 | Use of aminoglycoside resistance gene |
| 7258998 | Cell culture medium |